Edwards Lifesciences logo

Edwards LifesciencesNYSE: EW

Profile

Sector:

Healthcare

Country:

United States

IPO:

27 March 2000

Next earnings report:

06 February 2025

Last dividends:

N/A

Next dividends:

N/A
$40.97 B
-49%vs. 3y high
98%vs. sector
-82%vs. 3y high
14%vs. sector
-vs. 3y high
-vs. sector
-56%vs. 3y high
67%vs. sector

Price

after hours | Fri, 01 Nov 2024 23:58:03 GMT
$68.01+$0.99(+1.48%)

Dividend

No data over the past 3 years
$1.35 B$1.36 B
$1.35 B$3.07 B

Analysts recommendations

Institutional Ownership

EW Latest News

Edwards Lifesciences Corporation Is Being Sued For Violating Securities Laws And The Schall Law Firm Urges Affected Shareholders To Reach Out
accesswire.com02 November 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2024 and July 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 13, 2024.

EDWARDS LIFESCIENCES has been Sued for Securities Fraud after Stock Plummets 31%; Contact the Firm before December 13 Class Action Deadline (NYSE:EW)
globenewswire.com02 November 2024 Sentiment: NEGATIVE

Investors in Edwards Lifesciences Corporation who have lost money are urged to reach out to BFA Law before the legal deadline of December 13, 2024.

EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
prnewswire.com01 November 2024 Sentiment: NEGATIVE

NEW YORK, Nov. 1, 2024 /PRNewswire/ -- The Rosen Law Firm, a worldwide law firm focused on investor rights, is reminding buyers of Edwards Lifesciences Corporation (NYSE: EW) securities from February 6, 2024, to July 24, 2024, that the deadline to become a lead plaintiff is December 13, 2024. If you bought securities during this time, you might be eligible for compensation without having to pay any upfront fees or costs, thanks to a contingency fee agreement.

EW CLASS ACTION NOTE: Contact BFA Law by December 13 Court Deadline in Edwards Lifesciences Securities Fraud Lawsuit (NYSE:EW)
accesswire.com01 November 2024 Sentiment: NEGATIVE

On November 1, 2024, Bleichmar Fonti & Auld LLP, a prominent securities law firm, announced that a lawsuit has been initiated against Edwards Lifesciences Corporation (NYSE:EW) and some of its top executives for possible breaches of federal securities laws. If you have invested in Edwards Lifesciences, you are invited to find more details by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation.

Edwards Lifesciences Corporation Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – EW
accesswire.com01 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110404&wire=1 or reach out to Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit – EW
accesswire.com01 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110399&wire=1 or reach out to Joseph E. Levi, Esq.

Edwards Lifesciences Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights – EW
accesswire.com01 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110391&wire=1 or reach out to Joseph E. Levi, Esq.

EW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
globenewswire.com01 November 2024 Sentiment: NEGATIVE

NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- This is an advertisement from a law firm. Bronstein, Gewirtz & Grossman, LLC, a well-known law firm in the country, informs investors that a class action lawsuit has been initiated against Edwards Lifesciences Corporation (“Edwards” or “the Company”) (NYSE: EW) and some of its executives.

December 13, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against EW
accesswire.com01 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110386&wire=1 or reach out to Joseph E. Levi, Esq.

Contact Levi & Korsinsky by December 13, 2024 Deadline to Join Class Action Against Edwards Lifesciences Corporation (EW)
accesswire.com01 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 1, 2024 / If you experienced a loss from your investment in Edwards Lifesciences Corporation (NYSE:EW) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=110343&wire=1 or reach out to Joseph E. Levi, Esq.

What type of business is Edwards Lifesciences?

Edwards Lifesciences Corporation is an American company headquartered in Irvine, California, specializing in the production and distribution of medical equipment for monitoring structural heart diseases and intensive therapy. It was founded in 1958. It is the world's leading manufacturer of cardiovascular system valves and means for their replacement or repair. It is also a global leader in the field of hemodynamic monitoring systems used to measure the cardiovascular function of patients. The company's products and solutions can be divided into several groups: transcatheter therapy, surgical therapy, intensive therapy.

What sector is Edwards Lifesciences in?

Edwards Lifesciences is in the Healthcare sector

What industry is Edwards Lifesciences in?

Edwards Lifesciences is in the Medical Devices industry

What country is Edwards Lifesciences from?

Edwards Lifesciences is headquartered in United States

When did Edwards Lifesciences go public?

Edwards Lifesciences initial public offering (IPO) was on 27 March 2000

What is Edwards Lifesciences website?

https://www.edwards.com

Is Edwards Lifesciences in the S&P 500?

Yes, Edwards Lifesciences is included in the S&P 500 index

Is Edwards Lifesciences in the NASDAQ 100?

No, Edwards Lifesciences is not included in the NASDAQ 100 index

Is Edwards Lifesciences in the Dow Jones?

No, Edwards Lifesciences is not included in the Dow Jones index

When was Edwards Lifesciences the previous earnings report?

No data

When does Edwards Lifesciences earnings report?

The next expected earnings date for Edwards Lifesciences is 06 February 2025